Physician profile
Michael Steven Gart
NPI 1033420062
$3,347.48
in general payments reported to CMS, 2019-2025
12 companies · $272 in 2025
The $272 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $566 · 2020: $321 · 2021: $554 · 2022: $787 · 2023: $580 · 2024: $268 · 2025: $272.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,120.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,119.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axogen | $1,137.47 | 2019-2025 | Avance Nerve Graft |
| Integra Lifesciences Corporation | $740.53 | 2019-2022 | |
| Endo Pharmaceuticals INC. | $505.80 | 2019-2023 | Xiaflex |
| Acumed LLC | $455.38 | 2020-2023 | Acumed |
| Endo USA, INC. | $186.99 | 2024-2025 | Xiaflex |
| Osteomed LLC | $121.83 | 2021 | |
| Ossur Americas, INC. | $76.51 | 2024 | I-Digits Quantum |
| Glaxosmithkline, LLC. | $39.99 | 2024 | |
| Depuy Synthes Sales INC. | $30.40 | 2021 | |
| Peerless Surgical INC. | $29.47 | 2023 | |
| Medartis INC. | $12.82 | 2021 | |
| Trimed, INC. | $10.29 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Gart listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.